Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
Information source: University Hospital, Geneva
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Healthy; Immunosuppressed; Asthmatic; Neuromuscular Diseases
Phase: N/A
Status: Completed
Sponsored by: University Hospital, Geneva Official(s) and/or principal investigator(s): Klara M Posfay-Barbe, MD, MS, Principal Investigator, Affiliation: University Hospitals of Geneva
Summary
This study aims to identify clinical symptoms and outcomes, as well as response to
anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during
the current pandemic.
Clinical Details
Official title: Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: ABCB1 polymorphisms
Eligibility
Minimum age: N/A.
Maximum age: 16 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- suspicion of H1N1 infection
Exclusion Criteria:
- Not available for a 30 days follow-up
Locations and Contacts
Children's Hospital of Geneva, HUG, Geneva, GE 1211, Switzerland
Additional Information
Starting date: October 2009
Last updated: December 10, 2012
|